Company Profiles

driven by the PitchBook Platform

Adarza BioSystems

Adarza BioSystems
2008 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series C LATEST DEAL TYPE
$17M LATEST DEAL AMOUNT
14 INVESTORS
Description

Developer of a biological assay platform intended to measure clinical and point-of-care samples. The company's label-free diagnostic platform is capable of simultaneous detection of hundreds of analytes in a single drop of fluid, enabling highly multiplexed protein detection with high sensitivity and specificity.

Formerly Known As
Pathologics Associates
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Primary Office
Lennox TEC Center
150 Lucius Gordon Drive, Suite 110
West Henrietta, NY 14586
United States

+1 (636) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adarza BioSystems’s full profile, request a free trial.

Adarza BioSystems Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series C) 19-Jan-2017 $17M 000.00 0000 Completed Generating Revenue
9. Grant 21-Mar-2016 0000 000.00 Completed Generating Revenue
8. Later Stage VC (Series B) 15-Mar-2016 000 000.00 0000 Completed Generating Revenue
7. Later Stage VC (Series A) 16-Jul-2014 00.00 00.00 000.00 Completed Generating Revenue
6. Grant 14-May-2013 0000 00000 Completed Startup
5. Grant 01-Jan-2013 00000 00000 Completed Startup
4. Grant 01-Jan-2012 000.00 00000 Completed Startup
3. Grant 01-Jan-2010 00000 00000 Completed Startup
2. Early Stage VC $100K $100K Completed Startup
1. Grant 01-Sep-2009 $1.8M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Adarza BioSystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series A 374,274 $0.001000 $18.2 $18.2 1x $18.2 11.78%
To view this company’s complete Cap Table, request access »

Adarza BioSystems Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
5 Prime Ventures Venture Capital Minority 000 0000 000000 0
RiverVest Venture Partners Venture Capital Minority 000 0000 000000 0
Holton Capital Group Venture Capital Minority 000 0000 000000 0
Lewis & Clark Ventures Venture Capital Minority 000 0000 000000 0
BioGenerator Not-For-Profit Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Adarza BioSystems Executive Team (7)

Name Title Board
Seat
Contact
Info
Bryan Witherbee President
Preston Keller Ph.D Head, Missouri Operations & Vice President, Business Development
Christopher Striemer Ph.D Vice President, Engineering

4 Former Executives

You’re viewing 3 of 7 executives. Get the full list »

Adarza BioSystems Board Members (10)

Name Representing Role Since Contact
Info
Andrew Jay Next47 Board Member 000 0000
Benjamine Miller Ph.D Adarza BioSystems Co-Founder & Board Member 000 0000
Brian Hopcraft Lewis & Clark Ventures Board Member 000 0000
David Smoller Ph.D Self Board Member 000 0000
Heiner Dreismann Ph.D Self Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com